NCT04007536 - A Study of Potential Treatment-Responsive Biomarkers and Clinical Outcomes in Hunter Syndrome | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 23, 2019

Primary Completion Date

March 1, 2024

Study Completion Date

March 1, 2024

Conditions

Mucopolysaccharidosis II

Interventions

OTHER

No Intervention

Trial Locations (6)

UNC Children's Research Institute, Chapel Hill

UCSF Benioff Children's Hospital, Oakland

"UPMC , Children's Hospital of Pittsburgh"

Erasmus Medical Center, Rotterdam

Birmingham Children's Hospital, Birmingham

Manchester Centre for Genomic Medicine, Manchester